-
Je něco špatně v tomto záznamu ?
Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas and Paired Normal Mucosae Reveals Cyclin D1 Deregulation and Compensatory Effect of Cyclin D2
J. Novotný, V. Bandúrová, H. Strnad, M. Chovanec, M. Hradilová, J. Šáchová, M. Šteffl, J. Grušanović, R. Kodet, V. Pačes, L. Lacina, KS. Jr, J. Plzák, M. Kolář, T. Vomastek,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
16-29032A
Agentura Pro Zdravotnický Výzkum České Republiky
18-11908S
Grantová Agentura České Republiky
Operational Programme Research, Development and Education under the project "Center for Tumor Ecology - Research of the Cancer Microenvironment Supporting Cancer Growth and Spread" (reg. No. CZ.02.1.01/0.0/0.0/16_019/0000785)
Ministerstvo Školství, Mládeže a Tělovýchovy
Research and Development for Innovations Operational Program under project no. CZ.1.05/2.1.00/19.0400
Ministerstvo Školství, Mládeže a Tělovýchovy
NV16-29032A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
32224897
DOI
10.3390/cancers12040792
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Aberrant regulation of the cell cycle is a typical feature of all forms of cancer. In head and neck squamous cell carcinoma (HNSCC), it is often associated with the overexpression of cyclin D1 (CCND1). However, it remains unclear how CCND1 expression changes between tumor and normal tissues and whether human papillomavirus (HPV) affects differential CCND1 expression. Here, we evaluated the expression of D-type cyclins in a cohort of 94 HNSCC patients of which 82 were subjected to whole genome expression profiling of primary tumors and paired normal mucosa. Comparative analysis of paired samples showed that CCND1 was upregulated in 18% of HNSCC tumors. Counterintuitively, CCND1 was downregulated in 23% of carcinomas, more frequently in HPV-positive samples. There was no correlation between the change in D-type cyclin expression and patient survival. Intriguingly, among the tumors with downregulated CCND1, one-third showed an increase in cyclin D2 (CCND2) expression. On the other hand, one-third of tumors with upregulated CCND1 showed a decrease in CCND2. Collectively, we have shown that CCND1 was frequently downregulated in HNSCC tumors. Furthermore, regardless of the HPV status, our data suggested that a change in CCND1 expression was alleviated by a compensatory change in CCND2 expression.
Institute of Anatomy 1st Faculty of Medicine Charles University 128 00 Prague Czech Republic
Institute of Microbiology of the Czech Academy of Sciences 142 00 Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20019419
- 003
- CZ-PrNML
- 005
- 20201123123334.0
- 007
- ta
- 008
- 201103s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/cancers12040792 $2 doi
- 035 __
- $a (PubMed)32224897
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Novotný, Jiří $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20 Prague, Czech Republic. Department of Informatics and Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, 160 00 Prague, Czech Republic.
- 245 10
- $a Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas and Paired Normal Mucosae Reveals Cyclin D1 Deregulation and Compensatory Effect of Cyclin D2 / $c J. Novotný, V. Bandúrová, H. Strnad, M. Chovanec, M. Hradilová, J. Šáchová, M. Šteffl, J. Grušanović, R. Kodet, V. Pačes, L. Lacina, KS. Jr, J. Plzák, M. Kolář, T. Vomastek,
- 520 9_
- $a Aberrant regulation of the cell cycle is a typical feature of all forms of cancer. In head and neck squamous cell carcinoma (HNSCC), it is often associated with the overexpression of cyclin D1 (CCND1). However, it remains unclear how CCND1 expression changes between tumor and normal tissues and whether human papillomavirus (HPV) affects differential CCND1 expression. Here, we evaluated the expression of D-type cyclins in a cohort of 94 HNSCC patients of which 82 were subjected to whole genome expression profiling of primary tumors and paired normal mucosa. Comparative analysis of paired samples showed that CCND1 was upregulated in 18% of HNSCC tumors. Counterintuitively, CCND1 was downregulated in 23% of carcinomas, more frequently in HPV-positive samples. There was no correlation between the change in D-type cyclin expression and patient survival. Intriguingly, among the tumors with downregulated CCND1, one-third showed an increase in cyclin D2 (CCND2) expression. On the other hand, one-third of tumors with upregulated CCND1 showed a decrease in CCND2. Collectively, we have shown that CCND1 was frequently downregulated in HNSCC tumors. Furthermore, regardless of the HPV status, our data suggested that a change in CCND1 expression was alleviated by a compensatory change in CCND2 expression.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bandúrová, Veronika $u Institute of Anatomy, 1st Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic. Department of Otorhinolaryngology, Head and Neck Surgery, 1st Faculty of Medicine, Charles University, Faculty Hospital Motol, 150 06 Prague, Czech Republic.
- 700 1_
- $a Strnad, Hynek $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20 Prague, Czech Republic.
- 700 1_
- $a Chovanec, Martin $u Department of Otorhinolaryngology, 3rd Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic.
- 700 1_
- $a Hradilová, Miluše $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20 Prague, Czech Republic.
- 700 1_
- $a Šáchová, Jana $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20 Prague, Czech Republic.
- 700 1_
- $a Šteffl, Martin $u Department of Otorhinolaryngology, 3rd Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic.
- 700 1_
- $a Grušanović, Josipa $u Institute of Microbiology of the Czech Academy of Sciences, 142 00 Prague, Czech Republic.
- 700 1_
- $a Kodet, Roman $u Department of Pathology and Molecular Medicine, Charles University, 2nd Faculty of Medicine and Faculty Hospital Motol, 150 06 Prague, Czech Republic.
- 700 1_
- $a Pačes, Václav $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20 Prague, Czech Republic.
- 700 1_
- $a Lacina, Lukáš $u Institute of Anatomy, 1st Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic.
- 700 1_
- $a Jr, Karel Smetana $u Institute of Anatomy, 1st Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic.
- 700 1_
- $a Plzák, Jan $u Department of Otorhinolaryngology, Head and Neck Surgery, 1st Faculty of Medicine, Charles University, Faculty Hospital Motol, 150 06 Prague, Czech Republic.
- 700 1_
- $a Kolář, Michal $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20 Prague, Czech Republic.
- 700 1_
- $a Vomastek, Tomáš $u Institute of Microbiology of the Czech Academy of Sciences, 142 00 Prague, Czech Republic.
- 773 0_
- $w MED00173178 $t Cancers $x 2072-6694 $g Roč. 12, č. 4 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32224897 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201103 $b ABA008
- 991 __
- $a 20201123123333 $b ABA008
- 999 __
- $a ind $b bmc $g 1586196 $s 1109617
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 12 $c 4 $e 20200326 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
- GRA __
- $a 16-29032A $p Agentura Pro Zdravotnický Výzkum České Republiky
- GRA __
- $a 18-11908S $p Grantová Agentura České Republiky
- GRA __
- $a Operational Programme Research, Development and Education under the project "Center for Tumor Ecology - Research of the Cancer Microenvironment Supporting Cancer Growth and Spread" (reg. No. CZ.02.1.01/0.0/0.0/16_019/0000785) $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a Research and Development for Innovations Operational Program under project no. CZ.1.05/2.1.00/19.0400 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a NV16-29032A $p MZ0
- LZP __
- $a Pubmed-20201103